Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.
| dc.contributor.author | Dhawan, Ravinder | |
| dc.contributor.author | Diels, Joris K. | |
| dc.contributor.author | van de Velde, Helgi | |
| dc.contributor.author | Spencer, Michael D. | |
| dc.contributor.author | Delforge, Michel | |
| dc.contributor.author | Dimopoulos, Meletios A. | |
| dc.contributor.author | De Samblanx, Hadewijch M. | |
| dc.contributor.author | Roussou, Maria G. | |
| dc.contributor.author | Zervas, Konstantinos | |
| dc.contributor.author | Katodritou, Eirini | |
| dc.contributor.author | Sargin, Deniz | |
| dc.contributor.author | Hulin, Cyrille | |
| dc.contributor.author | Ahlberg, Lucia | |
| dc.contributor.author | De La Rubia, Javier | |
| dc.contributor.author | Ganguly, Rita | |
| dc.date.accessioned | 2021-03-04T13:52:52Z | |
| dc.date.available | 2021-03-04T13:52:52Z | |
| dc.identifier.citation | Dimopoulos M. A. , De Samblanx H. M. , Roussou M. G. , Zervas K., Katodritou E., Sargin D., Hulin C., Ahlberg L., De La Rubia J., Ganguly R., et al., "Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.", 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 4 - 07 Aralık 2010, cilt.116, ss.1247-1248 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_7eb09f26-2a76-4f39-a404-b3f0b98be9a7 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/86491 | |
| dc.language.iso | eng | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Hematoloji | |
| dc.subject | HEMATOLOJİ | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.title | Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study. | |
| dc.type | Bildiri | |
| dc.contributor.department | , , | |
| dc.identifier.volume | 116 | |
| dc.contributor.firstauthorID | 137578 |
Bu öğenin dosyaları:
| Dosyalar | Boyut | Biçim | Göster |
|---|---|---|---|
|
Bu öğe ile ilişkili dosya yok. |
|||
Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.
-
Bildiri [64839]